The latest from DTC Perspectives

FDA Says No on Common Use of Ad Words

Friday, 10 April 2009, 08:51 AM

The FDA took widespread action against drug companies who have used the popular ad words on Google. FDA rules require that any mention of a drug name with its indication requires full fair balance. Drug companies have been short cutting that rule by assuming the one click away process for ad words was sufficient. For example consumers who type in a disease would see a two line side ad that gave the drug name that treats the disease with a one line description of its effectiveness. If they clicked they would go to the company site loaded with fair balance.

For example, type in birth control and get an ad that says how effective a named medication is for preventing pregnancy. That is illegal under current promotional regulations. Drug companies have been using these ads for a long time and FDA has finally ruled that short ads without fair balance are unacceptable, even with an easy click to fair balance.

On April 3, 14 letters referencing 48 drugs were sent out to many major drug companies telling them to cease and desist from this practice. Obviously, this makes ad words harder to execute. Drug companies will now have to make no claims about a drug or show any indication of what it is for.

Our editor of DTC Perspectives, Mark Tosh, got a response to some follow-up questions on the letters from FDA. They say drug companies can either do reminder ads with nothing mentioned except the drug name or use disease awareness ads. The FDA said that space limitation is no excuse for not including fair balance. They also said that many drug ads had followed the rules when using ad words.

I do not believe drug companies are going to lose much by dropping the indication or a brief claim line. If a consumer enters a disease name and a reminder ad appears with just a brand name, the consumer will still understand the brand is a likely treatment. The letters, however, were a clear warning that a new era is here with increased vigilance from FDA. I doubt drug companies will drop the ad word use and instead will comply using more reminder ads. Perhaps the loss of the indication tag line makes for fewer click troughs but I doubt a significant drop off. It will make an interesting analysis from Google.               

Related articles

FDA and DTC

There are some critics who hope serious restrictions will be placed on DTC advertising in 2009. These anti-DTC folks include some politicians, consumer advocates,

DTC and Retention

DTC is almost always used for awareness building. Pfizer is now using it to maintain current users on Lipitor. A radio spot explicitly fights back against plans trying

Spending Down But Not Out!

DTC spending for full year 2008 is now officially in the books. Nielsen says down 18% from $5.3 billion in 2007 to $4.3 in 2008. It is a disappointing but not an

INSIGHTS ALERT: Reported Spending for DTC Ads Falls by Almost $1 Billion in 2008

The expectations of a down year for DTC advertising in 2008 were correct. But few, if anyone, expected the decline in "reported" ad dollars to exceed 18%, or roughly $1

The DTC Myth?

Ad Age recently ran a story on the growth in sleep aids despite cuts in DTC spending. Jim Edwards wrote a provocative blog on March 5 in BNET that questions the basic

Read all related articles

DTC and You

The DTC National Conference

Register Now for The DTC National Conference 
April 7-9, 2010, Washington DC. The Formum for DTC 
Thought Leaders

 FREE Subscription to our Magazine
Start a free subscription now to the industry's leading
publication focused soley on DTC marketing,
 DTC Perspectives Magazine is published quarterly.

Subscribe to DTC Insights

The DTC Marketer's Executive Brief - DTC INSIGHTS
takes all the information and data pertinent to DTC
and analyzes it for a busy pharma marketer.

Subscribe to Bob Ehrlich’s newsletter

A weekly blog column from DTCPI CEO Bob Ehrlich
that reflects his observations on key trends affecting
our industry.

     Visit us on Facebook
DTC Perspectives, Inc is now on Facebook. Stay
Informed on the latest trends in the industry.


ABOUT SSL CERTIFICATES